Culture
Alnylam has to solve its Amvuttra heart drug problem Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing.
Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing.
Dr. Kai NakamuraChief Science CorrespondentPublished Nov 12, 2026 at 10:59 PM EST · 1 min read
Alnylam has to solve its Amvuttra heart drug problem Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing. Alnylam is heavily dependent on its heart drug Amvuttra for growth — and sales have been slowing.
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.